Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Symplicity Spyral renal denervation

Tag: Symplicity Spyral renal denervation

Medtronic hypertension device: Symplicity Spyral outlook after SPYRAL AFFIRM results
  • Medical Devices

Medtronic Reports Significant Blood Pressure Reduction in SPYRAL AFFIRM Renal Denervation Study

Megan Wood6 hours ago012 mins

Why the Medtronic hypertension device Symplicity Spyral matters after SPYRAL AFFIRM data and an FDA label update that leaves the indication unchanged.

Read More

Categories

  • Healthcare IT (25)
  • Industry Insights (335)
  • Lifestyle and Wellness (24)
  • Medical Devices (43)
  • Pharmaceuticals (88)
  • Uncategorized (1)

Recent Posts

  • Shilpa CDMO Invests $50 Million to Expand Peptide Manufacturing Capacity in India
  • Alembic Pharmaceuticals Q2 FY27 Profit Jumps 81% on Strong US Business
  • Apollo Hospitals Q2 FY27 Results: Net Profit Rises 32% as Revenue Grows 23%
  • NHS Launches World-First Multi-Cancer Blood Test Trial Across 200 GP Practices
  • Edwards Lifesciences’ PASCAL System Shows Positive One-Year Results in CLASP II TR Trial
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.